FOXK1 and neoplasm: The FOXK1 stable transfectants group showed a significant increase in the proliferation rate and tumour vessels compared with those observed in the vector group, whereas the knockdown of FHL2 inhibited the growth rate and tumour vessels in the FOXK1-overexpressed group.